To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
CD&R, Merck GHI and McKesson Ventures to invest in M2GEN
Clayton, Dubilier & Rice, the Merck Global Health Innovation Fund and McKesson Ventures have invested in M2GEN, a cancer data and informatics platform.
